+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Stents Market - Global Forecast 2026-2032- Product Image
Coronary Stents Market - Global Forecast 2026-2032- Product Image
Sale

Coronary Stents Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084219
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronary Stents Market is projected to reach USD 13.32 Billion in 2026. It is expected to continue growing at a CAGR of 6.15%, reaching USD 19.11 Billion by 2032.

Coronary stents remain a core technology in percutaneous coronary intervention (PCI), supporting revascularization for patients with coronary artery disease, one of the most common and costly manifestations of cardiovascular disease. The World Health Organization identifies cardiovascular diseases as the leading cause of death globally, and ischemic heart disease is a major contributor to that burden. This sustained clinical need keeps drug-eluting stents, bare-metal stents in limited indications, covered stents, and next-generation bioresorbable and polymer-optimized platforms central to interventional cardiology.

The coronary stents landscape is shaped by a shift toward evidence-based device selection, improved deliverability, thinner struts, more biocompatible polymers, and optimized drug-release profiles. Hospitals, cardiologists, payers, and regulators increasingly evaluate coronary stents not only on procedural success, but also on long-term safety outcomes, restenosis reduction, stent thrombosis risk, dual antiplatelet therapy considerations, and total cost of care.

Transformative Shifts in the Coronary Stents Landscape

The coronary stents landscape is moving from device-centric innovation to outcomes-centric cardiovascular care. Newer-generation drug-eluting stents have become the clinical standard in many PCI procedures because randomized trials and guideline updates have consistently supported their superior restenosis performance compared with older bare-metal stents. At the same time, radial access, intravascular imaging, physiology-guided PCI, and complex lesion techniques are changing how stents are selected, sized, deployed, and evaluated.

Commercial transformation is also accelerating. Procurement teams are emphasizing value-based purchasing, supply resilience, and proven clinical differentiation, while manufacturers are investing in next-generation coatings, ultra-thin platforms, drug-device combinations, and digital cath lab integration. Regulatory scrutiny remains high because coronary stents are high-risk implantable devices, making robust clinical evidence, post-market surveillance, and quality-system compliance essential for market access and brand trust.

Cumulative Impact of Artificial Intelligence on Coronary Stents

Artificial intelligence is becoming a cumulative enabler across the coronary stents value chain rather than a standalone product category. In clinical workflows, AI-assisted image analysis can support lesion assessment, vessel sizing, plaque characterization, and procedure planning when integrated with angiography, intravascular ultrasound, optical coherence tomography, and fractional flow reserve data. These capabilities are particularly relevant as complex PCI volumes rise and operators seek more consistent deployment decisions.

AI is also influencing research, manufacturing, and post-market evidence generation. Machine learning can help identify restenosis predictors, optimize stent geometry simulations, flag quality deviations in production, and analyze real-world outcomes from registries and electronic health records. Adoption will depend on validation, explainability, cybersecurity, interoperability, and regulatory alignment, especially because AI-enabled decision support in coronary intervention must demonstrate measurable clinical benefit and patient safety.

Key Regional Insights for Coronary Stents

Asia-Pacific is a high-priority region for coronary stents because of large patient populations, expanding cardiac catheterization capacity, rising diabetes prevalence, and improving access to PCI in China, India, Japan, South Korea, Australia, and ASEAN markets. Local manufacturing, price controls, and public reimbursement reforms are shaping competitive dynamics, particularly in India and China, where affordability and domestic innovation are strategically important.

North America remains a technology-leading region, supported by established PCI volumes, strong clinical trial infrastructure, FDA oversight, and rapid uptake of advanced imaging and physiology-guided intervention. Europe combines mature interventional cardiology networks with strict EU Medical Device Regulation requirements, making clinical evidence and post-market performance critical. Latin America is expanding access through private hospital investment, public cardiology programs, and improving specialist training, with Brazil and Mexico serving as important procedural hubs. The Middle East is strengthening tertiary cardiac care through government-backed health system modernization, while Africa continues to face infrastructure and affordability gaps even as urban cardiac centers, training partnerships, and procurement upgrades gradually improve access to coronary stents.

Key Group Insights Across Major Economic and Strategic Blocs

ASEAN countries are expanding PCI access through hospital modernization and growing specialist capacity, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines at different stages of adoption. The GCC is investing heavily in tertiary cardiac care, supported by high cardiovascular risk factors, noncommunicable disease strategies, and government-backed health system modernization. The European Union remains one of the most regulated and evidence-driven markets, where MDR compliance, notified body capacity, clinical documentation, device traceability, and post-market surveillance influence launch timelines and purchasing decisions.

BRICS economies are central to coronary stents demand because Brazil, Russia, India, China, and South Africa combine large cardiovascular disease burdens with active public health, procurement, and local manufacturing agendas. G7 countries continue to anchor premium technology adoption, clinical research, guideline influence, and reimbursement precedent setting across advanced PCI systems. NATO countries overlap significantly with high-income European and North American markets, where supply security, device traceability, cybersecurity for connected cath lab systems, and resilient healthcare procurement have become more important after recent global supply disruptions.

Key Country Insights in Coronary Stents

The United States leads in advanced coronary intervention, supported by FDA-regulated innovation, broad cath lab infrastructure, national quality registries, and strong use of adjunctive imaging in complex PCI. Canada emphasizes evidence-based reimbursement, provincial procurement, and quality outcomes, while Mexico and Brazil show growing demand through private hospitals, urban cardiac centers, and expanding cardiovascular care access. In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature PCI systems supported by clinical guideline adoption and structured reimbursement, with Germany standing out for device adoption and procedural capacity, while Russia faces a more complex environment shaped by localization, procurement, sanctions exposure, and geopolitical constraints.

China and India are major procedural markets driven by large coronary artery disease populations, domestic stent production, public pricing policies, and ongoing expansion of interventional cardiology access beyond top-tier cities. Japan and South Korea are technology-intensive markets with strong physician expertise, advanced imaging adoption, and high expectations for device performance and clinical evidence. Australia maintains a sophisticated cardiovascular care system with structured reimbursement, specialist-led clinical governance, and strong adherence to evidence-based practice, making it an important market for premium, evidence-backed coronary stent platforms.

Actionable Recommendations for Coronary Stents Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, not incremental feature claims. Manufacturers need randomized data, robust registries, subgroup evidence for diabetes, small vessels, bifurcations, long lesions, calcified lesions, and high-bleeding-risk patients, along with transparent post-market surveillance to support payer and clinician confidence. Partnerships with hospitals should focus on procedure standardization, imaging-guided optimization, and physician training that improves outcomes rather than only device utilization.

Executives should also strengthen regional market access strategies. In mature markets, value dossiers should link stent performance to reduced repeat revascularization, lower adverse event burden, and lower downstream costs. In emerging markets, affordability, local partnerships, physician education, regulatory readiness, and reliable supply chains are critical. Companies that combine proven device engineering with digital workflow integration, regulatory excellence, and evidence-based pricing will be better positioned for sustainable growth.

Research Methodology for Coronary Stents Market Analysis

A rigorous coronary stents market assessment should combine primary research with validated secondary sources. Primary inputs include interviews with interventional cardiologists, cath lab directors, hospital procurement leaders, distributors, payers, and regulatory specialists. Secondary sources should include WHO and national cardiovascular statistics, FDA and European regulatory databases, clinical guidelines, peer-reviewed trials, tender records, reimbursement documents, import-export data, and hospital procedure data where available.

The research framework should triangulate demand drivers, installed cath lab capacity, PCI procedure trends, product mix, pricing, reimbursement, regulatory pathways, access barriers, and competitive positioning without relying on unverified estimates. Data validation requires cross-checking reported utilization patterns, tender information, clinical adoption signals, registry evidence, and regional infrastructure constraints. This approach supports defensible, data-backed analysis while avoiding overreliance on vendor-reported claims.

Conclusion: Evidence-Driven Progress in Coronary Stents

The coronary stents market is advancing through a combination of clinical necessity, engineering refinement, and evidence-based care pathways. Drug-eluting stents remain the dominant platform in contemporary PCI, while competitive advantage increasingly depends on long-term safety, deliverability, complex lesion performance, biocompatibility, and integration with imaging and digital decision support.

Future industry progress will be strongest for stakeholders that align innovation with measurable outcomes, regional affordability, regulatory expectations, physician training, and resilient supply chains. As cardiovascular disease remains a leading global health challenge, coronary stents will continue to play a critical role in PCI while the market evolves toward precision, value, and data-backed performance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Coronary Stents Market, by Product Type
7.1. Introduction
7.2. Drug-Eluting Stents
7.2.1. Polymer-Based DES
7.2.2. Polymer-Free DES
7.3. Bare-Metal Stents
8. Coronary Stents Market, by Material
8.1. Introduction
8.2. Cobalt Chromium
8.3. Nitinol
8.4. Stainless Steel
9. Coronary Stents Market, by Coating
9.1. Introduction
9.2. Limus Family
9.3. Paclitaxel
10. Coronary Stents Market, by Stent Type
10.1. Introduction
10.2. Bare-Metal Stents
10.3. Drug-Eluting Stents
11. Coronary Stents Market, by Application
11.1. Introduction
11.2. Acute Myocardial Infarction
11.3. Chronic Coronary Artery Disease
12. Coronary Stents Market, by Age Group
12.1. Introduction
12.2. Pediatric
12.3. Adult
12.4. Geriatric
13. Coronary Stents Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Cardiac Centers
13.4. Hospitals
14. Coronary Stents Market, by Distribution Channel
14.1. Introduction
14.2. Offline
14.3. Online
15. Coronary Stents Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. Europe
15.4. North America
15.5. Latin America
15.6. Africa
15.7. Middle East
16. Coronary Stents Market, by Group
16.1. Introduction
16.2. NATO
16.3. G7
16.4. BRICS
16.5. European Union
16.6. ASEAN
16.7. GCC
17. Coronary Stents Market, by Country
17.1. Introduction
17.2. China
17.3. United States
17.4. Japan
17.5. India
17.6. Germany
17.7. United Kingdom
17.8. Australia
17.9. France
17.10. South Korea
17.11. Italy
17.12. Canada
17.13. Russia
17.14. Brazil
17.15. Mexico
17.16. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. B Braun Melsungen AG
19.3. Becton, Dickinson and Company
19.4. Biosensors International Group, Ltd.
19.5. Biotronik SE & Co. KG
19.6. Boston Scientific Corporation
19.7. Cook Medical Incorporated
19.8. Elixir Medical Corporation
19.9. Integer Holdings Corporation
19.10. Johnson & Johnson Services, Inc.
19.11. Lepu Medical Technology
19.12. Medtronic PLC
19.13. Meril Life Sciences Private Limited
19.14. MicroPort Scientific Corporation
19.15. REVA Medical, Inc.
19.16. Siemens Healthineers AG
19.17. Stentys SA
19.18. Terumo Corporation
19.19. Translumina GmbH
19.20. Vascular Concepts Limited
20. Key Experts
List of Figures
FIGURE 1. Global Coronary Stents Market, Years Considered for the Study
FIGURE 2. Global Coronary Stents Market, Research Design
FIGURE 3. Global Coronary Stents Market, Research Framework
FIGURE 4. Global Coronary Stents Market, Data Triangulation
FIGURE 5. Global Coronary Stents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Coronary Stents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Coronary Stents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Coronary Stents Market Size, by Material, 2025 vs 2032 (%)
FIGURE 9. Global Coronary Stents Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Coronary Stents Market Size, by Coating, 2025 vs 2032 (%)
FIGURE 11. Global Coronary Stents Market Size, by Coating, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Coronary Stents Market Size, by Stent Type, 2025 vs 2032 (%)
FIGURE 13. Global Coronary Stents Market Size, by Stent Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Coronary Stents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Coronary Stents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Coronary Stents Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 17. Global Coronary Stents Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Coronary Stents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Coronary Stents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Coronary Stents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Coronary Stents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Coronary Stents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Coronary Stents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Coronary Stents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Coronary Stents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Coronary Stents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Coronary Stents Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Coronary Stents Market Segmentation & Coverage
TABLE 2. Global Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Drug-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Drug-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Drug-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Polymer-Based DES Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Polymer-Based DES Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Polymer-Based DES Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Polymer-Free DES Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Polymer-Free DES Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Polymer-Free DES Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Bare-Metal Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Bare-Metal Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Bare-Metal Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 17. Global Cobalt Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Cobalt Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Cobalt Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Nitinol Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Nitinol Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Nitinol Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Stainless Steel Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Stainless Steel Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Stainless Steel Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 27. Global Limus Family Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Limus Family Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Limus Family Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Paclitaxel Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Paclitaxel Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Paclitaxel Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 34. Global Bare-Metal Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Bare-Metal Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Bare-Metal Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Drug-Eluting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Drug-Eluting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Drug-Eluting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 41. Global Acute Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Acute Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Acute Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Chronic Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Chronic Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Chronic Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 48. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 58. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Europe Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Europe Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Europe Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 88. Europe Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 89. Europe Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 90. Europe Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 91. Europe Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Europe Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 93. Europe Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Europe Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. North America Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. North America Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. North America Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 98. North America Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 99. North America Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 100. North America Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 101. North America Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. North America Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 103. North America Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. North America Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. Latin America Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Latin America Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Latin America Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 108. Latin America Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 109. Latin America Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 110. Latin America Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 111. Latin America Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Latin America Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 113. Latin America Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Latin America Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Africa Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Africa Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Africa Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 118. Africa Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 119. Africa Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 120. Africa Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 121. Africa Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Africa Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 123. Africa Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Africa Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. Middle East Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Middle East Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. Middle East Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 128. Middle East Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 129. Middle East Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 130. Middle East Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 131. Middle East Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Middle East Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 133. Middle East Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Middle East Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. Global Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. NATO Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. NATO Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. NATO Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 139. NATO Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 140. NATO Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 141. NATO Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 142. NATO Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. NATO Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 144. NATO Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. NATO Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. G7 Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. G7 Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. G7 Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 149. G7 Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 150. G7 Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 151. G7 Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 152. G7 Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. G7 Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 154. G7 Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. G7 Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. BRICS Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. BRICS Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. BRICS Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 159. BRICS Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 160. BRICS Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 161. BRICS Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 162. BRICS Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. BRICS Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 164. BRICS Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. BRICS Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. European Union Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. European Union Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. European Union Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 169. European Union Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 170. European Union Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 171. European Union Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 172. European Union Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. European Union Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 174. European Union Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. European Union Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. ASEAN Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. ASEAN Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. ASEAN Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 179. ASEAN Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 180. ASEAN Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 181. ASEAN Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 182. ASEAN Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. ASEAN Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 184. ASEAN Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. ASEAN Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. GCC Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. GCC Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. GCC Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 189. GCC Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 190. GCC Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 191. GCC Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 192. GCC Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. GCC Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 194. GCC Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. GCC Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Global Coronary Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 197. China Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 198. China Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. China Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 200. China Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 201. China Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 202. China Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 203. China Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. China Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 205. China Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. China Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. United States Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 208. United States Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. United States Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 210. United States Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 211. United States Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 212. United States Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 213. United States Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. United States Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 215. United States Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. United States Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. Japan Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 218. Japan Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Japan Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 220. Japan Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 221. Japan Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 222. Japan Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 223. Japan Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Japan Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 225. Japan Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Japan Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. India Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 228. India Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. India Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 230. India Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 231. India Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 232. India Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 233. India Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. India Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 235. India Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. India Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Germany Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 238. Germany Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Germany Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 240. Germany Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 241. Germany Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 242. Germany Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 243. Germany Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Germany Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 245. Germany Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Germany Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. United Kingdom Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 248. United Kingdom Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. United Kingdom Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 250. United Kingdom Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 251. United Kingdom Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 252. United Kingdom Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 253. United Kingdom Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. United Kingdom Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 255. United Kingdom Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. United Kingdom Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. Australia Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 258. Australia Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. Australia Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 260. Australia Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 261. Australia Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 262. Australia Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 263. Australia Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. Australia Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 265. Australia Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Australia Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. France Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 268. France Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. France Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 270. France Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 271. France Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 272. France Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 273. France Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. France Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 275. France Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. France Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. South Korea Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 278. South Korea Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. South Korea Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 280. South Korea Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 281. South Korea Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 282. South Korea Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 283. South Korea Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. South Korea Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 285. South Korea Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. South Korea Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 287. Italy Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 288. Italy Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. Italy Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 290. Italy Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 291. Italy Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 292. Italy Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 293. Italy Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Italy Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 295. Italy Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Italy Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. Canada Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 298. Canada Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Canada Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 300. Canada Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 301. Canada Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 302. Canada Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 303. Canada Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. Canada Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 305. Canada Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. Canada Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Russia Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 308. Russia Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. Russia Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 310. Russia Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 311. Russia Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 312. Russia Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 313. Russia Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. Russia Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 315. Russia Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. Russia Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. Brazil Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 318. Brazil Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. Brazil Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 320. Brazil Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 321. Brazil Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 322. Brazil Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 323. Brazil Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. Brazil Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 325. Brazil Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Brazil Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 327. Mexico Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 328. Mexico Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 329. Mexico Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 330. Mexico Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 331. Mexico Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 332. Mexico Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 333. Mexico Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 334. Mexico Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 335. Mexico Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Mexico Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 337. Spain Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 338. Spain Coronary Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. Spain Coronary Stents Market Size, by Drug-Eluting Stents, 2017-2032 (USD Million)
TABLE 340. Spain Coronary Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 341. Spain Coronary Stents Market Size, by Coating, 2017-2032 (USD Million)
TABLE 342. Spain Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 343. Spain Coronary Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 344. Spain Coronary Stents Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 345. Spain Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 346. Spain Coronary Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. Global Coronary Stents Market Share, by Key Player, 2025
TABLE 348. Global Coronary Stents Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Incorporated
  • Elixir Medical Corporation
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic PLC
  • Meril Life Sciences Private Limited
  • MicroPort Scientific Corporation
  • REVA Medical, Inc.
  • Siemens Healthineers AG
  • Stentys SA
  • Terumo Corporation
  • Translumina GmbH
  • Vascular Concepts Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.32 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.11 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Cobalt Chromium Coronary Stent Market - Global Forecast 2026-2032 - Product Image

Cobalt Chromium Coronary Stent Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Hydrophilic Coronary Stents Market - Global Forecast 2026-2032 - Product Image

Hydrophilic Coronary Stents Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2026-2034 - Product Image

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Coronary Stents Market Report 2026 - Product Image

Coronary Stents Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Coronary Stents - Global Strategic Business Report - Product Image

Coronary Stents - Global Strategic Business Report

  • Report
  • 342 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.